IMS Health Holdings Inc

IMS Health — Q2 2016 Earnings Presentation

19 slides from IMS Health's earnings presentation, Jul 27, 2016

  1. Slide 1: IMS Health Q2 2016 Earnings Call

    IMS Health Q2 2016 Earnings Call July 27, 2016 0

  2. Slide 2: Legal

    Legal This presentation should be viewed in conjunction with IMS Health’s Q2 2016 earnings call Safe Harbor Statement This presentation Thi t ti includes i l d “forward-looking “f d l ki statements”, t t t ” including i l di statements t t t regarding di future f t fi financial i l and d operating t

  3. Slide 3: 2nd Quarter Results

    2nd Quarter Results $M Revenue Adjusted EBITDA +8.4% 8 4% +6.7% 6 7% @ CFx @ CFx $802 $742 $238 $220 Q2 2016 Q2 2015 Q2 2016 Q2 2015 Note: Dollars are at actual foreign exchange rates. CFx is constant currency. EBITDA is “Adjusted EBITDA” as calculated in the appendix of this presentation 2

  4. Slide 4: 2nd Quarter Offering Revenue

    2nd Quarter Offering Revenue Offering 2nd Quarter Versus Prior Year Constant $M 2016 2015 Reported Currency Information $383 $374 2.5% 2.6% Technology Services $419 $368 13.8% 14.3% Total $802 $742 8.1% 8.4% Note: Dollars are at actual foreign exchange rates 3

  5. Slide 5: 2nd Quarter Geographic Revenue

    2nd Quarter Geographic Revenue Geography 2nd Quarter Versus Prior Year Constant $M 2016 2015 Reported Currency Developed Markets $671 $618 8.7% 7.9% Emerging Markets $131 $124 5.4% 11.0% Total $802 $742 8.1% 8.4% Note: Dollars are at actual foreign exchange rates Prior year adjusted to conform with

  6. Slide 6: 2nd Quarter Adjusted EBITDA

    2nd Quarter Adjusted EBITDA 2nd Quarter Versus Prior Year Constant $M 2016 2015 Reported Currency Adjusted EBITDA (1) $238 $220 8.1% 6.7% Adjusted EBITDA margin 29.7% 29.7% 0 Bps (46) Bps Note: Dollars are at actual foreign exchange rates (1) See reconciliations of non-GAAP items in appendix 5

  7. Slide 7: 2nd Quarter P&L

    2nd Quarter P&L At reported FX rates $M (except per share data) 2016 2015 Net Income $24 $47 Diluted Earnings per Share $0.07 $0.14 Adjusted Net Income (1) $139 $125 Adjusted Diluted Earnings per Share (1) $0.41 $0.37 (1) See reconciliations of non-GAAP items in appendix 6

  8. Slide 8: Year-to-date Revenue

    Year-to-date Revenue Offering Year-to-date Versus Prior Year Constant $M 2016 2015 Reported Currency Information $759 $728 4.2% 5.7% Technology Services $817 $646 26 6% 26.6% 27 8% 27.8% Total $1,576 $1,374 14.7% 16.1% Geography Year-to-date Versus Prior Year Developed Markets $1,321 $1,145 15.4% 15

  9. Slide 9: Year-to-date P&L

    Year-to-date P&L $M (except per share data) 2016 2015 Adjusted EBITDA (1) $474 $436 Adjusted EBITDA margin 30.1% 31.7% Net Income / (Loss) $67 $345 Diluted Earnings / (Loss) per Share $0 20 $0.20 $1 01 $1.01 Adjusted Net Income (1) $279 $261 Adjusted Diluted EPS (1) $0.83 $0.76 (1) See reconciliatio

  10. Slide 10: 2nd Quarter Balance Sheet Items & Metrics

    2nd Quarter Balance Sheet Items & Metrics $M 2016 2015 Cash & Cash Equivalents $368 $396 (1) p Balance of Debt (2) Principal $4,565 $ , $4,266 $ , (1) Net Debt $4,197 $3,870 (1) Gross Leverage Ratio 4.9x 4.8x (1) Net Cash Provided by Operating Activities $111 $186 Capital Expenditures and Additions

  11. Slide 11: Full-Year 2016 Guidance

    Full-Year 2016 Guidance Full-Year 2016 Revenue Growth Reported (1) 10 – 12% Constant Currency 10 – 12% Adjusted EBITDA Growth Reported (1) 8.5 – 10.5% Constant Currency 7.5 – 9.5% Adjusted j Net Income Growth Reported (1) 5 – 7% Constant Currency 8 – 10% Adjusted Diluted EPS Reported (1) 7 – 9% Cons

  12. Slide 12: Q3 2016 Guidance

    Q3 2016 Guidance Q3 2016 Revenue Growth Reported (1) 8 – 9% Constant Currency 7.5 – 8.5% Adjusted EBITDA Growth Reported (1) 8 – 9% Constant Currency 4 – 5% Adjusted Net Income Growth Reported (1) (1) – (2)% Constant Currency 0 – 1% Adjusted Diluted EPS Reported (1) (0.5) – (1.5)% Constant Currency

  13. Slide 13: Q&A

    Q&A 12

  14. Slide 14: Appendix: Non-GAAP Financial Measures

    Appendix: A di Non-GAAP N GAAP Financial Measures 13

  15. Slide 15: Net Income to Adjusted EBITDA

    Net Income to Adjusted EBITDA Three Months Ended Six Months Ended June 30, June 30, (in millions) 2016 2015 2016 2015 Net Income $ 24 $ 47 $ 67 $ 345 Provision for (benefit from) income taxes 7 13 27 (227) Other (income) loss, net 2 ( ) (6) 7 ( ) (10) Interest expense 47 43 93 80 Interest income (1)

  16. Slide 16: Net Income to Adjusted Net Income & Per Share Data

    Net Income to Adjusted Net Income & Per Share Data Three Months Ended Six Months Ended June 30, June 30, (in millions, except per share data) 2016 2015 2016 2015 Net Income $ 24 $ 47 $ 67 $ 345 Provision for (benefit from) income taxes 7 13 27 (227) Amortization associated with purchase accounting 5

  17. Slide 17: Unlevered Free Cash Flow

    Unlevered Free Cash Flow Three Months Ended Six Months Ended June 30, 30 June 30, 30 (in millions) 2016 2015 2016 2015 Net Cash Provided by Operating Activities $ 111 $ 186 $ 96 $ 215 Capital expenditures (19) (16) (32) (25) Additions to computer software (34) (30) (60) (53) Free Cash Flow $ 58 $ 14

  18. Slide 18: Gross Leverage Ratio

    Gross Leverage Ratio (in millions) Gross Debt as of June 30, 2016 $ 4,565 Adjusted EBITDA for the year ended December 31, 2015 886 Less: Adjusted EBITDA for the six months ended June 30, 2015 (436) Add: Adjusted EBITDA for the six months ended June 30, 2016 474 Adjusted EBITDA for the twelve months

  19. Slide 19: Non-GAAP Adjustments By Income Statement Line Items

    Non-GAAP Adjustments By Income Statement Line Items Three Months Ended Six Months Ended June 30, June 30, (in millions) 2016 2015 2016 2015 Non-GAAP adjustments included in: Operating costs of information, exclusive of depreciation and amortization 2 1 3 2 Direct and incremental costs of technology

IMS Health — Q2 2016 Earnings Presentation on 6ix